Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Paclitaxel + Cisplatin in Early HER2- Breast Cancer
NCT03201861Phase 3Recruiting
- Sponsor
- Renji Hospital
- Start
- Jul 2017
- Primary completion
- Aug 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cisplatin in breast cancer, sponsored by Renji Hospital. Started Jul 2017; status: recruiting.
02
Drugs
cisplatin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03201861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03201861.